Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aura Biosciences, Inc.

6.25
-0.2515-3.87%
Volume:95.89K
Turnover:606.80K
Market Cap:387.43M
PE:-3.29
High:6.70
Open:6.43
Low:6.20
Close:6.50
Loading ...

As Of March 31, 2025, Aura Biosciences Had Cash And Cash Equivalents And Marketable Securities Of $128M, Sufficient To Fund Its Operations Into 2H Of 2026

Benzinga
·
15 May

Aura Biosciences Q1 2025 EPS $(0.55) Misses $(0.48) Estimate

Benzinga
·
15 May

Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants

THOMSON REUTERS
·
15 May

BRIEF-Aura Biosciences Q1 Operating Expenses USD 29.035 Million

Reuters
·
15 May

Aura Biosciences Q1 Operating Expenses USD 29.035 Million

THOMSON REUTERS
·
15 May

Press Release: Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights

Dow Jones
·
15 May

Aura Biosciences Inc expected to post a loss of 49 cents a share - Earnings Preview

Reuters
·
07 May

Meitu Founder Cai Wensheng Invests HK$650 Million to Acquire Whole Building of Former Empress Theatre, to Build AI-Web3 Entrepreneurship Center

Blockbeats
·
01 May

Aura Biosciences Inc (AURA) Receives a Buy from Scotiabank

TIPRANKS
·
03 Apr

BRIEF-Aura Biosciences Announces Appointment Of Teresa Bitetti To Board Of Directors

Reuters
·
02 Apr

Aura Biosciences Expands Board with New Director Appointment

TIPRANKS
·
02 Apr

Aura Biosciences appoints Bitetti to board of directors

TIPRANKS
·
02 Apr

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors

THOMSON REUTERS
·
02 Apr

Press Release: Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors

Dow Jones
·
02 Apr

Evercore ISI Sticks to Its Buy Rating for Aura Biosciences Inc (AURA)

TIPRANKS
·
01 Apr

US Stocks Likely To Open Mixed: 'Expect Volatility. Buckle Up,' Says Expert

Benzinga
·
27 Mar

Aura Energy Limited (AURA) Gets a Buy from Petra Capital

TIPRANKS
·
27 Mar

Aura Biosciences Down Nearly 12%, on Track for Record Low Close -- Data Talk

Dow Jones
·
27 Mar

Aura Biosciences Stock (AURA) Continues to Slide Despite Promising Clinical Progress

TIPRANKS
·
26 Mar

Aura Biosciences Is Maintained at Market Outperform by Citizens Capital Markets

Dow Jones
·
26 Mar